New data will help clinicians choose between offering high-dose methotrexate in between or after R-CHOP therapy in patients with diffuse large B-cell lymphoma (DLBCL) at risk of CNS relapse, UK researchers say. A retrospective study compared intercalated therapy with end of treatment therapy in 334 patients undergoing R-CHOP chemotherapy, and found that both may be ...
Study shows when to use methotrexate with R-CHOP in diffuse large B-cell lymphoma
By Emma Wilkinson
23 Jun 2020